v3 Template
C

CoVaRR-Net

Healthcare and Biotechnology ~3K employees
Founded
--
Employees (Est.)
~3K
172 leaders known
Total Funding
$6.0M
Funding Rounds
1
Last Funding
2024-01-30

About CoVaRR-Net

CoVaRR-Net (Coronavirus Variants Rapid Response Network) was established in March 2021 to support Canada's response to the SARS-CoV-2 pandemic. It mobilized expertise nationwide to conduct high-impact research, support public health decision-making, and build infrastructure for infectious disease research. The network aimed to assess how variants affect people in Canada and globally, detect and stop their spread, and prepare for future pandemics. Operations concluded on March 31, 2025, due to funding discontinuation.

Products & Services

Biobank, Data Platform & Bioethics:A platform for storing and managing biological data with ethical guidelines.
Computational Analysis, Modelling and Evolutionary Outcomes (CAMEO):An initiative for computational modeling of viral evolution and outcomes.
Canadian Consortium of Academic Biosafety Level 3 Laboratories (CCABL3):A consortium for high-level biosafety research on infectious diseases.
Central Laboratory Services:Centralized lab services supporting research on SARS-CoV-2 variants.
Wastewater Surveillance Research Group (WWSRG):A group focused on tracking SARS-CoV-2 through wastewater surveillance.
Indigenous Engagement, Development, and Research (CIEDAR):A pillar for culturally responsive research and Indigenous-led pandemic strategies.

Specialties

SARS-CoV-2 variant research Wastewater surveillance Computational biology and modeling Viral genomics and sequencing Immunology and vaccine protection Indigenous engagement in health research Public health and social policy impacts Antiviral strategies and therapeutics Host-pathogen interactions Bioethics in health research

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Grant
T: -
FT: Grant
A: 6000000
MR: -
FA: $6 million
FAN: 6000000
D: 2024-01-30
FD: 2024-01-30
1 investors
Grant Latest
2024-01-30
$6.0M
1 investor (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

M

Marc-André Langlois

Executive Director

C

Cecilia L. Jenkins

Network Operating Officer

LinkedIn (Pro only)
N

Nidhi Chaudhary

Network Coordinator

A

Angela L. Rasmussen

Research Scientist III and Host-Pathogen Interactions Pillar Co-Lead

C

Caroline Phaneuf

Director, President and Founder

R

Rebecca Burns

Social media, content creation

View 169 more team members with Pro

Unlock Full Team Directory

Recent News

CoVaRR-Net Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Healthcare and Biotechnology
Company Size
~3K employees (est.)

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro